Omideon.com
website under construction

Omideon, a spin-out company from Pneumagen, is focused on developing glycan targeted carbohydrate binding molecules (CBMs) as a new therapeutic modality for the treatment of cancer.

Please contact Omideon for more information

Signup here for more information